Ovid Therapeutics

OVID

Börsenwert 496 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Takeda Pharmaceutical Company Tokyo, Japan	2,49 Mio. $	–	–	–
2	2 BVF Inc San Francisco, California	1,27 Mio. $	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	869.918 $	-142.414 $	-472.666	-15 %
4	4 Sio Capital Management New York	736.337 $	–	–	–
5	5 Acadian Asset Management Boston, Massachusetts	693.000 $	+6.113 $	+20.290	+1 %
6	6 Renaissance Technologies New York	691.242 $	+322.846 $	+1.071.509	+105 %
7	7 Kennedy Capital Management St Louis, Missouri	495.618 $	-69.460 $	-230.536	-13 %
8	8 Driehaus Capital Management Chicago, Illinois	461.923 $	–	–	–
9	9 BlackRock New York	451.636 $	-750.409 $	-2.490.572	-65 %
10	10 Madison Avenue Partners New York	432.618 $	-347.779 $	-1.154.261	-47 %
11	11 Adage Capital Partners Boston, Massachusetts	379.385 $	–	–	–
12	12 Millennium Management New York	347.165 $	+317.068 $	+1.052.334	Neu
13	13 Wells Fargo San Francisco, California	251.751 $	-7.060 $	-23.433	-3 %
14	14 GSA Capital Partners London, United Kingdom	245.000 $	+91.019 $	+302.087	+69 %
15	TA 15 TLS Advisors Miami, Florida	225.000 $	–	–	–
16	16 Affinity Asset Advisors New York	220.214 $	–	–	–
17	17 Geode Capital Management Boston, Massachusetts	212.284 $	-207.191 $	-687.658	-52 %
18	18 Rosalind Advisors Toronto, Ontario, Canada	164.950 $	+150.650 $	+500.000	Neu
19	19 Rubric Capital Management (New York) New York	157.868 $	-1,46 Mio. $	-4.837.436	-91 %
20	20 Assenagon Asset Management Senningerberg, Luxembourg	143.711 $	-37.726 $	-125.210	-22 %
21	21 Goldman Sachs New York	93.634 $	+54.050 $	+179.389	+172 %
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	75.958 $	+44.340 $	+147.161	+177 %
23	23 State Street Boston, Massachusetts	74.898 $	-345.011 $	-1.145.075	-83 %
24	24 Squarepoint New York	72.949 $	-13.367 $	-44.365	-17 %
25	25 Marshall Wace London, United Kingdom	54.358 $	+49.630 $	+164.721	Neu

Ovid Therapeutics OVID Börsenwert 496 Mio. $

Ovid Therapeutics

OVID

Börsenwert 496 Mio. $